DEA Sets New Import, Export Restrictions for Methiopropamine
The Drug Enforcement Administration is listing methiopropamine, a central nervous stimulant that is structurally related to the schedule II stimulants methamphetamine and amphetamine, under schedule I of the Controlled Substances Act, it said in a notice released Dec. 8. “This…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle methiopropamine," DEA said. The listing takes effect Jan. 9.